Gilead gains on HIV drug&#39;s test results
34170
LOS ANGELES (CBS.MW) -- Shares of Gilead Sciences climbed Thursday, touching a 52-week high at one point, after the biotechnology firm reported positive results from its recently approved HIV drug Truvada.
368328
For the second time in less than a month, Vanda Pharmaceuticals has announced positive results from late-stage testing of one of its drugs, sending its stock soaring 69 percent and raising the possibility that a big pharmaceutical firm would make a move to buy the nearly four-year-old company.
472236
By Anne Krishnan, The News & Observer, Raleigh, N.C.  Feb. 7--Sales of Trimeris' HIV drug rose 20 percent last year, but the therapy could face increased competition in 2007.
641877
Health-care products maker Johnson &  Johnson  won U.S. approval to sell a new HIV drug called  Intelence for patients with resistance to other therapies, U.S.  officials said on Friday.
708119
Pfizer Inc.  said on Tuesday  pivotal-stage trials found that adding its experimental HIV  drug maraviroc to a regimen of the best-available drugs  resulted in twice as many patients achieving suppression of the  virus.
156434
An experimental cancer drug made by Abbott Laboratories Inc. passed its first round of human testing about six months faster than usual, thanks to a new program that aims to speed drug development.
265570
Tablets of the drug etravirine were approved Friday by the Food and Drug Administration for the treatment of HIV infection in adults
36213
A cheap drug has been discovered which could cut Aids-related deaths in African children by almost half. Tests on the new antibiotic drug in Zambia were so successful that the trial was halted early to make the drug available more quickly.
281372
Better test results for Elan Corp's key  Antegren drug lifted the Irish company's shares more than 10  percent as analysts said the data improved its chances of  becoming the leading multiple sclerosis treatment.
532662
Gilead Sciences Inc. , a leading producer of HIV drugs, said yesterday it plans to acquire biotech firm Myogen Inc. for about $2.5 billion in cash, signaling a surprising expansion into treatments for pulmonary diseases.
745892
Sanofi-Aventis said on Friday that  U.S. regulators had approved wider use for its colon cancer  drug Eloxatin, lifting shares in the world's third-largest  pharmaceuticals group.
480434
Shares of Elan Corp., Ireland&#39;s biggest drugmaker, rose as much as 7.7 percent after a newspaper reported that the company&#39;s US partner Biogen Idec Inc.
402115
Two drugs provide good results in preliminary trials.
584007
Investors reward the drugmaker for positive study results.
155787
Bristol-Myers Squibb (NYSE: BMY) and Gilead Sciences (Nasdaq: GILD) have taken a much-needed step that should make patients&#39; lives easier even as it improves the companies&#39; results.
451417
Gilead announces its fourth-quarter financial results.
693379
questions over testing of a key HIV/AIDS drug before a US-backed roll-out of the treatment across the continent. Ingelheim to hide adverse effects of nevirapine when used to try to prevent mother-to-child HIV transmission.